Biologicals and biosimilars - Interpharma

Putting the focus on patients

Biologicals and biosimilars

The process of manufacturing a medicinal product involves investments and risks.

Overview Biologicals and biosimilars Generics List of pharmaceutical specialities Paediatric medicinal products Parallel imports Regulation of medicinal products The Pharma Cooperation Code Use of medicinal products

Medicinal products obtained from living cells in complex biotechnological processes nowadays play a central role in the therapy and diagnosis of diseases such as cancer and diabetes.

Interferons, monoclonal antibodies, coagulation factors, and insulin and other hormones are examples of these products, which are known collectively as biologicals. In contrast to standard chemical products, these medicines consist of several highly complex large molecules and can be extremely sensitive to changes (for example of temperature or the composition of the nutrient medium) during their manufacture. The manufacture of biologicals is a technically demanding and intricate operation.

For some years now, Switzerland has also been authorising biosimilars – imitations of the original biologicals – once the patent on the original product has expired. Unlike copies of chemical medicines (generics), biosimilars are never entirely identical to the original active substance but only similar to the original, hence the name biosimilar. Biosimilars are not generics. The procedure used to authorise them is therefore more complex and requires more surveillance measures than for standard generics.

Further information

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2023

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more


Contact us

read more


Latest information and media contacts for media representatives

read more